Company Captor Capital Corp Canadian Securities Exchange
Equities
CA14075H1038
Pharmaceuticals
Business Summary
Sales per Business
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Cannabis
100.0
%
| 33 | 100.0 % | 42 | 100.0 % | +27.80% |
Sales per region
CAD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 33 | 100.0 % | 42 | 100.0 % | +27.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Zorbas
CEO | Chief Executive Officer | 53 | 01/18/01 |
Jing Peng
DFI | Director of Finance/CFO | 47 | 01/14/01 |
Gavin Davidson
IRC | Investor Relations Contact | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Klein
BRD | Director/Board Member | 50 | 21/19/21 |
Kyle Appleby
BRD | Director/Board Member | 48 | 01/14/01 |
John Zorbas
CEO | Chief Executive Officer | 53 | 01/18/01 |
Brady Cobb
CHM | Chairman | - | 18/21/18 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 51,934,299 | 51,034,862 ( 98.27 %) | 0 | 98.27 % |
Company contact information
Sector
Sales per Business
Sales per region
1st Jan change | Capi. | |
---|---|---|
+37.65% | 6.11B | |
-19.68% | 4.33B | |
+4.49% | 3.22B | |
-15.69% | 2.96B | |
-5.64% | 2.42B | |
+44.89% | 1.92B | |
-12.71% | 1.61B | |
-4.27% | 1.57B | |
-14.86% | 1.51B |